Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

"Transparency reports" on industry payments to physicians and teaching hospitals.

Steinbrook R, Ross JS.

JAMA. 2012 Mar 14;307(10):1029-30. doi: 10.1001/jama.2012.211. Epub 2012 Feb 14. No abstract available.

PMID:
22336624
2.

Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.

Rosenthal MB, Mello MM.

N Engl J Med. 2013 May 30;368(22):2052-4. doi: 10.1056/NEJMp1305090. No abstract available.

3.

The Sunshine Act: commercial conflicts of interest and the limits of transparency.

Wilson M.

Open Med. 2014 Jan 14;8(1):e10-3. eCollection 2014. No abstract available.

4.

Transparency urged over research payments.

Check E.

Nature. 2007 Aug 16;448(7155):738. No abstract available.

PMID:
17700667
5.

Shadows amid sunshine: regulating financial conflicts in medical research.

Saver RS.

Chest. 2014 Feb;145(2):379-385. doi: 10.1378/chest.13-1719.

PMID:
24493509
6.

Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program.

Marshall DC, Jackson ME, Hattangadi-Gluth JA.

Mayo Clin Proc. 2016 Jan;91(1):84-96. doi: 10.1016/j.mayocp.2015.10.016. Review.

7.

Already feeling the heat: Docs rethinking payments as Sunshine Act looms.

Lee J.

Mod Healthc. 2013 Jul 1;43(26):12-3. No abstract available.

PMID:
23878901
8.

The Sunshine Act--effects on physicians.

Agrawal S, Brennan N, Budetti P.

N Engl J Med. 2013 May 30;368(22):2054-7. doi: 10.1056/NEJMp1303523. No abstract available.

9.

Open Payments Program (aka the Sunshine Act) makes public debut.

Schmidt C.

J Natl Cancer Inst. 2014 Sep 10;106(9). pii: dju312. doi: 10.1093/jnci/dju312. Print 2014 Sep. No abstract available.

PMID:
25214569
10.

The Sunshine Act: it's for real now.

Katayama AC.

WMJ. 2013 Apr;112(2):96-7. No abstract available.

11.

Shining a light on the Sunshine Act.

Peck AA.

J Med Assoc Ga. 2013;102(2):28. No abstract available.

PMID:
24006732
12.

Drug companies will have to report all payments to US doctors from March 2014.

Roehr B.

BMJ. 2013 Feb 7;346:f826. doi: 10.1136/bmj.f826. No abstract available.

PMID:
23393117
13.

Industry paid $6.5 bn to US physicians and hospitals in 2014.

McCarthy M.

BMJ. 2015 Jul 7;350:h3697. doi: 10.1136/bmj.h3697. No abstract available.

PMID:
26152208
14.

Disclosure UK: transparency should no longer be an optional extra.

Adlington K, Godlee F.

BMJ. 2016 Jul 6;354:i3730. doi: 10.1136/bmj.i3730. No abstract available.

PMID:
27383187
15.

GMC says it can't force doctors to disclose payments from drug companies.

Torjesen I.

BMJ. 2016 Jul 7;354:i3806. doi: 10.1136/bmj.i3806. No abstract available.

PMID:
27390102
16.

Disclosure UK website gives "illusion of transparency," says Goldacre.

Kmietowicz Z.

BMJ. 2016 Jul 6;354:i3760. doi: 10.1136/bmj.i3760. No abstract available.

PMID:
27384062
17.

Payments to physicians, medical schools to be illuminated under new reform law.

Kuehn BM.

JAMA. 2010 Jun 9;303(22):2237-8. doi: 10.1001/jama.2010.724. No abstract available.

PMID:
20530769
18.

An MS patient loses trust when she finds out her doctor is paid by drug companies.

Wolston M.

Health Aff (Millwood). 2011 Dec;30(12):2449-52. doi: 10.1377/hlthaff.2011.0094. No abstract available.

19.

Two years of sunshine: has openness about payments reduced industry influence in healthcare?

Lenzer J.

BMJ. 2016 Aug 25;354:i4608. doi: 10.1136/bmj.i4608. No abstract available.

PMID:
27562781
20.

Information disclosure and the Physician Payments Sunshine Act.

Kimball AB.

JAMA. 2011 Sep 14;306(10):1087; author reply 1087-8. doi: 10.1001/jama.2011.1298. No abstract available.

PMID:
21917577

Supplemental Content

Support Center